← Back to Search

Behavioural Intervention

Acupuncture for Opioid Use Disorder (AcuPOM Trial)

N/A
Waitlist Available
Led By Jessica Bayner, MD
Research Sponsored by Albert Einstein College of Medicine
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
≥18 years old
Receiving methadone treatment at an OTP through the Montefiore network for at least 12 weeks, with no dose change in 14 days to ensure treatment stability
Must not have
Have pending surgery or invasive pain management procedure
Have an acutely or exacerbation of psychotic, suicidal, or homicidal conditions that preclude the ability to participate
Timeline
Screening 3 weeks
Treatment Varies
Follow Up upon completion of the study, up to four weeks
Awards & highlights
No Placebo-Only Group

Summary

This trial aims to see how patients with chronic pain and opioid use disorder will react to acupuncture treatment and if it affects their mood. The results could help guide future studies for patients considering acupuncture for their conditions

Who is the study for?
This trial is for individuals with chronic pain who also struggle with opioid use disorder, including those experiencing mood swings. Participants should be interested in trying acupuncture as a treatment option.
What is being tested?
The study tests the effectiveness of Modified Battlefield Acupuncture combined with the National Acupuncture Detoxification Association protocol on chronic pain, opioid dependency, and mood changes.
What are the potential side effects?
Acupuncture may cause minor side effects such as bruising, bleeding at needle sites, dizziness or fainting. Most people find it relatively safe and experience minimal discomfort.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am 18 years old or older.
Select...
I have been on stable methadone treatment for at least 12 weeks without any dose changes in the last 14 days.
Select...
I experience chronic pain with a severity of at least moderate.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I have a surgery or invasive pain procedure planned.
Select...
I do not have severe mental health issues that would stop me from participating.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~at 0, 2, and 4 week study visits, up to four weeks total
This trial's timeline: 3 weeks for screening, Varies for treatment, and at 0, 2, and 4 week study visits, up to four weeks total for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Acceptability/Satisfaction
Adherence to acupuncture treatments
Feasibility - Percentage Consented
+1 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: BFA + NADA protocolExperimental Treatment1 Intervention
Modified BFA + NADA treatment, twice per week over 4 weeks for a total of 8 treatments at the clinic. All participants will also have the small seeds placed to facilitate at-home acupressure treatment

Find a Location

Who is running the clinical trial?

Albert Einstein College of MedicineLead Sponsor
296 Previous Clinical Trials
11,689,433 Total Patients Enrolled
10 Trials studying Chronic Pain
2,035 Patients Enrolled for Chronic Pain
National Institute on Drug Abuse (NIDA)NIH
2,607 Previous Clinical Trials
3,329,915 Total Patients Enrolled
64 Trials studying Chronic Pain
84,250 Patients Enrolled for Chronic Pain
Jessica Bayner, MDPrincipal InvestigatorMontefiore Medical Center
~13 spots leftby Dec 2025